journal article·2026-07-25

Impact of Amphiphilic Balance on Nano–Bio Interactions of Peptide Amphiphile Nanostructures

Karla Bonic, Kailin Mooney, Li Xiang, Sadik Esener, Adem Yildirim

Publisher page

Abstract

Self-assembled peptide amphiphile (PA)-based nanostructures are promising biomaterials with their biocompatibility and highly tunable physical and chemical properties. Despite this promise, the interactions of PA nanostructures with biological systems have remained largely unexplored. Here, we investigate nano-bio interactions of self-assembled PA nanostructures using a series of PAs with varying amphiphilicities, achieved by tuning the hydrophilicity of the peptide backbone and payloads attached to them. We show that, while PAs with hydrophilic peptide backbones and payloads mostly disassembled in blood plasma, increasing overall hydrophobicity improved their stability. We also report that disassembled PAs can bind to blood biomolecules and binding shifted from albumin to lipoproteins with increasing hydrophobicity. In addition, we show that the membrane-binding affinity of PAs increases with increasing PA hydrophobicity, which also induces membrane disruption and cytotoxicity. The results of this study highlight the critical role of the overall amphiphilic balance of PAs on their interactions with biological molecules and cell membranes.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CEDAR, Knight Cancer Institute, School of Medicine

Oregon Health & Science University

Department of Biomedical Engineering, School of Medicine

Division of Oncological Sciences, Knight Cancer Institute, School of Medicine

Funding

Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University · National Institute of Neurological Disorders and Stroke · National Institute of Biomedical Imaging and Bioengineering

References (56)

Show source-provided references
1. 10.1021/acs.chemrev.1c0008910.1021/acs.chemrev.1c00089 ↗
2. 10.1021/acs.accounts.7b0029710.1021/acs.accounts.7b00297 ↗
3. 10.1021/acs.chemrev.1c0071210.1021/acs.chemrev.1c00712 ↗
4. 10.1039/c7cs00735c10.1039/c7cs00735c ↗
5. 10.1021/acs.biomac.7b0076410.1021/acs.biomac.7b00764 ↗
6. 10.1021/acs.accounts.3c0059210.1021/acs.accounts.3c00592 ↗
7. 10.1021/acs.nanolett.1c0173710.1021/acs.nanolett.1c01737 ↗
8. 10.1038/s41570-020-0215-y10.1038/s41570-020-0215-y ↗
9. 10.1021/nl202220q10.1021/nl202220q ↗
10. 10.1002/cbic.20230083110.1002/cbic.202300831 ↗
11. 10.1021/jacs.1c0613310.1021/jacs.1c06133 ↗
12. 10.1021/nl802813f10.1021/nl802813f ↗
13. 10.1021/acs.nanolett.5c0648110.1021/acs.nanolett.5c06481 ↗
14. 10.1021/acs.nanolett.5b0331310.1021/acs.nanolett.5b03313 ↗
15. 10.1039/b919446k10.1039/b919446k ↗
16. 10.1002/anie.20120294710.1002/anie.201202947 ↗
17. 10.1021/la300335510.1021/la3003355 ↗
18. 10.1002/adma.20250935910.1002/adma.202509359 ↗
19. 10.1002/smll.20251207310.1002/smll.202512073 ↗
20. 10.1016/j.jconrel.2011.09.06910.1016/j.jconrel.2011.09.069 ↗
21. 10.1021/acs.molpharmaceut.1c0004610.1021/acs.molpharmaceut.1c00046 ↗
22. 10.1021/acs.bioconjchem.9b0077110.1021/acs.bioconjchem.9b00771 ↗
23. 10.1021/acs.molpharmaceut.7b0095210.1021/acs.molpharmaceut.7b00952 ↗
24. 10.1016/j.addr.2016.04.03010.1016/j.addr.2016.04.030 ↗
25. 10.1016/j.addr.2020.08.00310.1016/j.addr.2020.08.003 ↗
26. 10.1016/j.addr.2016.04.02010.1016/j.addr.2016.04.020 ↗
27. 10.1038/nbt133910.1038/nbt1339 ↗
28. 10.1021/ar200017e10.1021/ar200017e ↗
29. 10.1021/mp100193h10.1021/mp100193h ↗
30. 10.1021/bi802356k10.1021/bi802356k ↗
31. 10.1371/journal.pone.005461110.1371/journal.pone.0054611 ↗
32. 10.1021/acs.jmedchem.2c0102110.1021/acs.jmedchem.2c01021 ↗
33. 10.1016/j.mam.2011.12.00210.1016/j.mam.2011.12.002 ↗
34. 10.1016/j.bcp.2026.11784610.1016/j.bcp.2026.117846 ↗
35. 10.1038/ncomms1609210.1038/ncomms16092 ↗
36. 10.1002/advs.20220161410.1002/advs.202201614 ↗
37. 10.1038/ncomms1567810.1038/ncomms15678 ↗
38. 10.1042/bj312072510.1042/bj3120725 ↗
39. 10.1023/b:pham.0000036926.54824.3710.1023/b:pham.0000036926.54824.37 ↗
40. 10.1021/acs.jmedchem.5b0072610.1021/acs.jmedchem.5b00726 ↗
41. 10.1038/nature1297810.1038/nature12978 ↗
42. 10.1021/acs.langmuir.9b0183710.1021/acs.langmuir.9b01837 ↗
43. 10.1021/acs.jpcb.5c0073710.1021/acs.jpcb.5c00737 ↗
44. 10.1021/am501673x10.1021/am501673x ↗
45. 10.1021/ma200675w10.1021/ma200675w ↗
46. 10.1111/j.1747-0285.2007.00610.x10.1111/j.1747-0285.2007.00610.x ↗
47. 10.1016/j.jconrel.2015.10.02910.1016/j.jconrel.2015.10.029 ↗
48. 10.1021/acs.chemrev.6b0000110.1021/acs.chemrev.6b00001 ↗
49. 10.1021/acs.jpclett.1c0373510.1021/acs.jpclett.1c03735 ↗
50. 10.1080/02652048.2024.238913510.1080/02652048.2024.2389135 ↗
51. 10.1016/j.chemphyslip.2008.04.00610.1016/j.chemphyslip.2008.04.006 ↗
52. 10.1021/acs.jpclett.5b0173910.1021/acs.jpclett.5b01739 ↗
53. 10.1016/j.bbamem.2006.02.02110.1016/j.bbamem.2006.02.021 ↗
54. 10.1016/j.bpj.2011.12.02910.1016/j.bpj.2011.12.029 ↗
55. 10.1039/c3tb20139b10.1039/c3tb20139b ↗
56. 10.1021/am404860q10.1021/am404860q ↗